NCKX1 (Sodium/Calcium/Potassium Exchanger 1), also known as SLC24A1, is a crucial protein involved in the transport of ions across cellular membranes. It is part of the solute carrier family and specifically belongs to the potassium-dependent sodium-calcium exchanger subfamily. This protein plays a vital role in maintaining ionic homeostasis within cells, which is essential for various physiological processes.The primary function of NCKX1 is to mediate the exchange of sodium and potassium ions for calcium ions across the plasma membrane. This exchange is critical in numerous cell types, particularly in the regulation of intracellular calcium levels. Calcium ions are fundamental signaling molecules in cells, involved in processes such as muscle contraction, neurotransmission, and hormone secretion. NCKX1 helps regulate these processes by controlling the cellular calcium concentration.
NCKX1 is known for its significant role in the retina, particularly in the photoreceptor cells, which are responsible for vision. In these cells, NCKX1 contributes to the recovery phase of phototransduction, the process by which light is converted into electrical signals. It helps in the rapid extrusion of calcium from photoreceptor cells, a crucial step in resetting these cells after activation by light.Mutations in the gene encoding NCKX1 have been associated with certain hereditary eye disorders, including cone-rod dystrophy and other retinal degenerative diseases. These conditions often lead to impaired vision or blindness, underscoring the importance of NCKX1 in visual health.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits the Na+/K+-ATPase, potentially increasing intracellular Na+ levels, which could indirectly influence NCKX1 activity by altering Na+ gradients. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
A cardiac glycoside that inhibits Na+/K+-ATPase, potentially affecting NCKX1 activity by altering sodium and potassium gradients. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
A sodium ionophore that increases intracellular sodium levels, potentially modulating NCKX1 activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that can influence intracellular calcium levels, potentially affecting NCKX1 function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another calcium channel blocker that may indirectly affect NCKX1 by altering cellular calcium dynamics. | ||||||
Isradipine | 75695-93-1 | sc-201467 sc-201467A | 10 mg 50 mg | $88.00 $324.00 | 1 | |
A calcium channel blocker, like verapamil and nifedipine, which could indirectly modulate NCKX1 activity. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
This compound also blocks calcium channels, potentially influencing the activity of NCKX1. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
A calcium channel blocker that could indirectly affect NCKX1 by altering calcium dynamics. | ||||||
Felodipine | 72509-76-3 | sc-201483 sc-201483A | 10 mg 50 mg | $91.00 $222.00 | 1 | |
Another agent in the calcium channel blocker class, potentially affecting NCKX1 activity. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Also a calcium channel blocker, potentially influencing NCKX1 activity. | ||||||